HPN
HPN (hepsin, also known as TMPRSS1) is a type II transmembrane serine protease of the peptidase S1 family. It cleaves extracellular substrates, including growth factor precursors, and its expression is linked to cancer progression, particularly prostate cancer. Browse Assay Genie's current range of HPN research reagents below, or read on for the biology behind the target.
HPN is a serine protease that cleaves extracellular substrates. It contributes to the proteolytic processing of growth factors such as HGF and MST1/HGFL, and it plays a role in cell growth and in the maintenance of cell morphology. It is also involved in the proteolytic processing of ACE2, and it mediates the cleavage of urinary UMOD, a step required for UMOD polymerisation. The enzyme is assigned EC 3.4.21.106 and is found at the cell membrane, including the apical cell membrane.
The HPN gene encodes a type II transmembrane serine protease that belongs to the peptidase S1 family. In HGNC it sits within two gene groups: scavenger receptor cysteine rich domain containing proteins and type II transmembrane serine proteases. The protein is cleaved into two chains: a catalytic serine protease chain and a non-catalytic scavenger receptor cysteine-rich chain. The two chains remain associated through a single disulfide bond. Alternative splicing of the gene produces multiple transcript variants. Researchers working with the hepsin protein should keep this two-chain organisation in mind when choosing detection strategies.
NCBI Gene summarises HPN as possibly involved in diverse cellular functions, including blood coagulation and the maintenance of cell morphology. Its expression is associated with the growth and progression of cancers, particularly prostate cancer, which has made it a frequent subject of oncology research. The gene has also been known by the symbol TMPRSS1. Mouse and rat both carry an orthologous gene, Hpn, which allows the biology of hepsin to be studied in rodent models.
HPN expression is associated with the growth and progression of cancers, particularly prostate cancer, making it a focus for tumour biology studies.
HPN contributes to the proteolytic processing of growth factors such as HGF and MST1/HGFL, so it is relevant to protease-dependent signalling.
HPN mediates the cleavage of urinary UMOD that is required for UMOD polymerisation, linking the protease to urinary protein biology.
HPN takes part in the proteolytic processing of ACE2, which makes it of interest in studies of cell-surface protease activity.
HPN is a serine protease that cleaves extracellular substrates. It contributes to the processing of growth factors such as HGF and MST1/HGFL, and of ACE2. It also cleaves urinary UMOD, which is required for UMOD polymerisation, and it plays a role in cell growth and cell morphology.
HPN is the symbol for hepsin, also called serine protease hepsin and previously TMPRSS1. It is a type II transmembrane serine protease. It is cleaved into a catalytic serine protease chain and a non-catalytic scavenger receptor cysteine-rich chain, joined by one disulfide bond.
HPN expression is associated with the growth and progression of cancers, particularly prostate cancer. Mouse and rat each have an orthologous gene named Hpn. Check the datasheet of any product for its validated reactivity before using it in rodent studies.
Growth factor substrates, membrane protease partners and related serine protease targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P05981; product specifications from Assay Genie datasheets.